Last reviewed · How we verify
NCT06159023
Conventional Bronchoscope With BAL vs. Thin Bronchoscope With BW to Diagnose Pulmonary TB
NA trial testing bronchial washing using a thin bronchoscope in Tuberculosis, Pulmonary in 132 participants. Currently enrolling.
31 December 2024
Quick facts
| Lead sponsor | Pusan National University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 132 |
| Start date | 15 December 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- bronchial washing using a thin bronchoscope
Conditions studied
- Tuberculosis, Pulmonary — all drugs for Tuberculosis, Pulmonary →
Sponsor
Pusan National University Hospital
Who can join
18 and older, any sex, with Tuberculosis, Pulmonary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the diagnostic yield of bronchoalveolar lavage (BAL) using a thick conventional bronchoscope and bronchial washing (BW) using a thin bronchoscope in the diagnosis of pulmonary tuberculosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06159023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tuberculosis, Pulmonary
Currently open trials in the same condition.
- NCT07077213 — 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients · recruiting
- NCT07271225 — Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting · NA · recruiting
- NCT06845618 — Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment · recruiting
- NCT06253715 — Shortened Regimen for Drug-susceptible TB in Children · Phase 3 · recruiting
- NCT06057519 — Pragmatic Optimized Rifampicin Trial · Phase 3 · recruiting
Other Pusan National University Hospital trials
Trials by the same sponsor.
- NCT07073365 — Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor The · Phase 2 · recruiting
- NCT06878495 — Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease · NA · not yet recruiting
- NCT06805123 — Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection · NA · recruiting
- NCT06752395 — Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions · NA · enrolling by invitation
- NCT07455552 — Comparison of Telemedicine-based and Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06159023 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pusan National University Hospital
- Last refreshed: 16 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06159023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing